XML 20 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Selected Quarterly Financial Data (unaudited)
12 Months Ended
Dec. 31, 2011
Selected Quarterly Financial Data (unaudited) [Abstract]  
Selected Quarterly Financial Data (unaudited)

16. Selected Quarterly Financial Data (unaudited)

Selected quarterly financial data for years ended December 31, 2011 and 2010 follows:

 

      September 30,       September 30,       September 30,       September 30,  
    Quarter Ended  
    March 31,     June 30,     September 30,     December 31,  
    2011     2011     2011     2011  

Net sales

  $ 23,116,949     $ 21,198,055     $ 24,383,110     $ 21,329,792  

Gross margin

    12,208,863     $ 12,241,693       13,103,608       6,975,073  

Net income (loss)

    19,732       (2,294,832     1,136,285       (5,901,051

Basic net income (loss) per share

  $ 0.00     $ (0.04   $ 0.02     $ (0.11

Diluted net income (loss) per share

    0.00       (0.04     0.02       (0.11

 

      September 30,       September 30,       September 30,       September 30,  
    Quarter Ended  
    March 31,     June 30,     September 30,     December 31,  
    2010     2010     2010     2010  

Net sales

  $ 23,843,901     $ 19,120,525     $ 21,084,081     $ 22,881,512  

Gross margin

    13,490,421       9,630,710       10,415,682       11,830,062  

Net loss

    (492,605     (1,359,389     (2,335,478     (196,963

Basic net loss per share

  $ (0.01   $ (0.02   $ (0.04   $ 0.00  

Diluted net loss per share

    (0.01     (0.02     (0.04     0.00  

 

 

The Company has determined that it is impracticable to break out the segment data for the unaudited quarterly data.

The following significant and infrequent charges were incurred during 2011:

 

   

Impairment of the Protector product line for $1.4 million, incurred during the second quarter of 2011

 

   

Losses on disposal of property and equipment of $0.8 million, related to surplus EVIDENCE.COM equipment and billing software, incurred in the second quarter of 2011.

 

   

A litigation judgment reserve for $3.3 million, incurred during the third quarter of 2011.

 

   

Excess inventory charges for the TASER X3 and first generation AXON product lines of $3.7 million, and impairment of associated tooling equipment of $2.0 million, incurred during the fourth quarter of 2011.